Is supra-ventricular arrhythmia a reason for the bad performance of the FlowTrac device?

doi:10.1186/cc5154

Critical Care
Volume 11
Issue 1

Viewing options:

Abstract
Full text
PDF (49KB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Umgelter A
Reindl W
Schmid RM
Huber W

on PubMed

Umgelter A
Reindl W
Schmid RM
Huber W
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Letter

Is supra-ventricular arrhythmia a reason for the bad performance of the FlowTrac device?

Andreas Umgelter , Wolfgang Reindl, Roland M Schmid and Wolfgang Huber

II Medizinische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München, Ismaningerstraße 22, 81644 München, Germany

author email corresponding author email

Critical Care 2007, 11:406doi:10.1186/cc5154


Published:	12 February 2007

See related research by Sander et al., http://ccforum.com/content/10/6/R164

First paragraph (this article has no abstract)

In their recent paper evaluating arterial waveform analysis as a tool to measure cardiac output (CO), Michael Sander and colleagues do not provide data on the heart rhythms of their cardiac surgery patients [1]. As the FloTrac (Flowtrac/Vigileo, Edwards Lifescience, Munich, Germany) device calculates CO from an arterial pressure-based algorithm, integrating vessel compliance and peripheral resistance effects, it seems plausible that these measurements may be influenced by cardiac arrhythmia.